Showing results (271-280 of 319) with videos related to

Sort By:
Pageof 32
Frontiers in Immunology|December 22, 2018
MicroRNA-31 Reduces the Motility of Proinflammatory T Helper 1 LymphocytesMarkus Bardua, Claudia Haftmann, Pawel Durek, et al.
Oncology Research and Treatment|June 1, 2025
Guidelines of Onkopedia: What Is New?Magdalena K Scheck, Salah-Eddin Al-Batran, Markus Borner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncologyDamian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
The Lancet. Oncology|February 26, 2017
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study GroupPeter Borchmann, Heinz Haverkamp, Andreas Lohri, et al.
Lancet (London, England)|February 26, 2013
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trialMathias J Rummel, Norbert Niederle, Georg Maschmeyer, et al.
Annals of Hematology|September 13, 2013
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Sabine Mousset, Dieter Buchheidt, Werner Heinz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III TrialMarianne Sinn, Marcus Bahra, Torsten Liersch, et al.
The Lancet. Oncology|April 2, 2026
Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical OncologySibylle C Mellinghoff, Blasius Liss, Jannik Stemler, et al.
Annals of Hematology|September 19, 2003
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Hermann Einsele, Hartmut Bertz, Jörg Beyer, et al.
The Journal of Antimicrobial Chemotherapy|February 15, 2008
Risk factors for breakthrough invasive fungal infection during secondary prophylaxisOliver A Cornely, Angelika Böhme, Dietmar Reichert, et al.
Pageof 32